Beatriz Morancho

Beatriz Morancho Armisen is a Research Director at ONA Therapeutics since March 2020, focusing on advancing research in therapeutic opportunities for HER2-positive breast cancer. Prior experience includes serving as a Senior Postdoctoral Researcher at Vall d'Hebron Institut d'Oncologia, from July 2009 to March 2020, where research centered on translational studies and mechanisms of resistance in cancer. Beatriz also worked as a Postdoctoral Researcher at Hospital Universitari Joan XXIII, investigating gene expression and metabolic regulation during obesity, and completed a PhD at Universitat Pompeu Fabra, studying the role of osmotic stress on T cell regulation, along with a brief tenure as a Visiting PhD student at the Medical Research Council. Educational credentials include a PhD in Biology and a Bachelor's degree in Biology from Universitat Pompeu Fabra.